Join members from the team leading the Engineered Genetic Control Systems for Advanced Therapeutics Mission Hub as they provide an overview of their expansive engineering biology programme. This webinar is part of a series taking place over 2025.
Objectives:
* Learn about the aims and objectives of this Engineering Biology Mission Hub
* Discover research and innovation activities taking place across the consortium
* Find out about opportunities to engage with the programme
Target audience:
This webinar is targeted primarily at communities within the engineering biology and biotechnology research and innovation ecosystem, for example:
* Businesses
* Innovators
* Researchers
* Investors
* Policymakers
* This webinar will also appeal to those working within the biomedicine sector such as clinicians.
We encourage anyone with an interest in how UK researchers and innovators are using engineering biology in addressing real-world challenges to attend.
About:
The Engineered Genetic Control Systems for Advanced Therapeutics Mission Hub aims to harness engineering biology to improve the safety and effectiveness of gene therapy and is led by Professor Susan Rosser at The University of Edinburgh, in collaboration with partners at:
* Imperial College London
* CRUK Scotland Institute (formerly Beatson Institute)
* University of Oxford
It is underpinned by UKRI’s investment in platform technologies, such as the Edinburgh Genome Foundry, a one-of-a-kind facility providing a fully automated platform for DNA assembly and phenotyping.
